Dr. Edgar H. Tan finished his Bachelor of Science (major in Biology) degree in Silliman University where he graduated with honors (cum laude) in 1982. He earned his medical degree at Cebu Doctors' College of Medicine. He was a consistent honor student, received a Faculty Silver Medal Award and graduated with honors (cum laude) in 1986.
He did his Post Graduate Internship at the Philippine General Hospital from 1986-1987. He passed his Philippine Medical Licensure Exam rank #15 in August of 1987. He decided to pursue further studies in the United States and did his Internal Medicine Residency Training at Lincoln Medical and Mental Health Center in New York, a program affiliated with the New York Medical College in Westchester, New York from 1989-1992. He served as the PGY-3 Chief Medical Resident from 1991-1992 and as PGY-4 Administrative Chief Medical Resident (ACMR) in the same program from 1992-1993 and received an award recognizing his excellent performance as ACMR by the graduating residents of that year. He subsequently pursued his Three-year Fellowship Training in Clinical and Invasive Cardiology at Metropolitan Hospital and Westchester County Medical Center Consortium, affiliated with New York Medical College Program from 1993-1996.
He practiced in the State of South Carolina after his training in New York with privileges in Marlboro Park Hospital in Bennettsville SC and McLeod Regional Hospital in Florence SC from 1996-1997. He holds an active medical license in the State of Carolina since 1996 until present. He came home to start his own medical practice in Cebu in February of 1998 at Cebu Doctors' University Hospital. His US training, expertise and active medical licensure in the State of South Carolina remain handy not only to the locals but also to the American retirees knowing that the expertise of an American-trained and licensed physician is available right in the heart of Cebu City.
Dr. Tan is board certified by the American Board of Internal Medicine and American Board of Cardiovascular Disease. He is also trained and certified in the field of Nuclear Cardiology. He is Board Certified by the Philippine College of Physicians as well. As a Fellow of the American College of Physicians and American College of Cardiology, he regularly travels abroad for his continuing medical education in the field of cardiology. His practice includes General Internal Medicine, Clinical as well as Interventional Cardiology i.e. diagnostic coronary angiography, percutaneous coronary intervention (stenting/angioplasty), permanent pacemaker implantation (single chamber & dual chamber pacers) to name a few. He is affiliated with Cebu Doctors' University Hospital /Cebu Cardiovascular Center where he was the former Section Head of the Cardiac Catheterization Laboratory & currently appointed as the Section Head of the Department of Cardiology. Dr. Tan received recognition and was awarded the Presidential Medal Award given at Cebu Doctors' University Hospital on Sept. 2, 2020 for his contribution using a radical approach in the treatment of a critically ill Covid-19 infected patient with the combined use of Therapeutic Plasma Exchange and Convalescent Plasma Therapy which was first in the Philippines. Subsequent Case Series of 15 severe to critical covid 19 patients using Plasmapheresis vs Standard of Care presentation during the 54th Annual Philippine College of the Philippines won First place during the Young Investigator Award Research Contest on May 6, 2024 at the SMX Convention Center. His office is located at Cebu Doctors' University Hospital Medical Arts Building 1, Suite 303-A, Osmeña Blvd. Cebu City Philippines. Office hours are 9am-12pm Mon-Sat. Tel: 032-511-2857 Mobile/Viber: 0918-457-4762 . By appointment only.About Me
Dr. Edgar H. Tan, a consistent honor student graduated Bachelor of Science major in Biology cum laude from Silliman University in 1982. A Faculty Silver Medal Awardee and graduated cum laude when he earned his Medical Degree from Cebu Doctors' College of Medicine in April of 1986.
He spent one year of post graduate internship at the prestigious Philippine General Hospital from May 1, 1986 to April 30, 1987 and subsequently passed his Philippine Medical Licensure Exam rank #15 in August of 1987. He pursued further training in Internal Medicine from 1989-1993 under the New York Medical College Program where he served as the Administrative Chief Medical Resident for one year. He subsequently did his Fellowship Training in Clinical/Invasive Cardiology under the consortium of Metropolitan & New York Medical College Program from 1993-1996. After his medical training in New York he practiced Internal Medicine/Invasive Cardiology in the State of South Carolina from 1996-1997 with privileges at Marlboro Park Hospital Bennettsville SC & McLeod Regional Medical Center in Florence SC. He holds an active medical license in the State of South Carolina from 1996 up to the present. He decided to come back to Cebu and practice his profession starting February 1998. His foresight at keeping his US medical license active inspite of practicing medicine outside the US has come handy for US expats currently in the Philippines wanting medical care recognized by US HMO's.
Dr. Tan is board certified by the American Board of Internal Medicine, American Board of Cardiovascular Disease and Philippine College of Physicians. He is also trained and certified in the field of Nuclear Cardiology. He is a Fellow of the American College of Physicians, American College of Cardiology and Philippine College of Physicians. His extensive background comes handy by making available the highest standard of US quality medical care right in the heart of Cebu City.
He is affiliated with Cebu Doctors' University Hospital, where he is currently the Section Head of Cardiology Department. He is also affiliated with UCMed and Perpetual Succour Hospital. His practice includes General Internal Medicine & Adult Clinical/Interventional Cardiology. He has admitting privileges at the University of Cebu Medical Center, Cebu Doctors' University Hospital & Perpetual Succour Hospital.
His office is located at Cebu Doctors' University Hospital Medical Arts Building 1, Suite 203-B, Osmeña Blvd. Cebu City Philippines. His office hours are 9am-12pm Mon-Sat. and 2pm to 5pm except Wed. and Sat. Tel: (032) 412-5136.
Email:EdgarTan62@yahoo.com or EdgarTanMD@gmail.com
Tuesday, July 01, 2025
About the Author
Dr. Edgar H. Tan finished his Bachelor of Science (major in Biology) degree in Silliman University where he graduated with honors (cum laude) in 1982. He earned his medical degree at Cebu Doctors' College of Medicine. He was a consistent honor student, received a Faculty Silver Medal Award and graduated with honors (cum laude) in 1986.
He did his Post Graduate Internship at the Philippine General Hospital from 1986-1987. He passed his Philippine Medical Licensure Exam rank #15 in August of 1987. He decided to pursue further studies in the United States and did his Internal Medicine Residency Training at Lincoln Medical and Mental Health Center in New York, a program affiliated with the New York Medical College in Westchester, New York from 1989-1992. He served as the PGY-3 Chief Medical Resident from 1991-1992 and as PGY-4 Administrative Chief Medical Resident (ACMR) in the same program from 1992-1993 and received an award recognizing his excellent performance as ACMR by the graduating residents of that year. He subsequently pursued his Three-year Fellowship Training in Clinical and Invasive Cardiology at Metropolitan Hospital and Westchester County Medical Center Consortium, affiliated with New York Medical College Program from 1993-1996.
He practiced in the State of South Carolina after his training in New York with privileges in Marlboro Park Hospital in Bennettsville SC and McLeod Regional Hospital in Florence SC from 1996-1997. He holds an active medical license in the State of Carolina since 1996 until present. He came home to start his own medical practice in Cebu in February of 1998 at Cebu Doctors' University Hospital. His US training, expertise and active medical licensure in the State of South Carolina remain handy not only to the locals but also to the American retirees knowing that the expertise of an American-trained and licensed physician is available right in the heart of Cebu City.
Dr. Tan is board certified by the American Board of Internal Medicine and American Board of Cardiovascular Disease. He is also trained and certified in the field of Nuclear Cardiology. He is Board Certified by the Philippine College of Physicians as well. As a Fellow of the American College of Physicians and American College of Cardiology, he regularly travels abroad for his continuing medical education in the field of cardiology. His practice includes General Internal Medicine, Clinical as well as Interventional Cardiology i.e. diagnostic coronary angiography, percutaneous coronary intervention (stenting/angioplasty), permanent pacemaker implantation (single chamber & dual chamber pacers) to name a few. He is affiliated with Cebu Doctors' University Hospital /Cebu Cardiovascular Center where he was the former Section Head of the Cardiac Catheterization Laboratory & currently appointed as the Section Head of the Department of Cardiology. Dr. Tan received recognition and was awarded the Presidential Medal Award given at Cebu Doctors' University Hospital on Sept. 2, 2020 for his contribution using a radical approach in the treatment of a critically ill Covid-19 infected patient with the combined use of Therapeutic Plasma Exchange and Convalescent Plasma Therapy which was first in the Philippines. Subsequent Case Series of 15 severe to critical covid 19 patients using Plasmapheresis vs Standard of Care presentation during the 54th Annual Philippine College of the Philippines won First place during the Young Investigator Award Research Contest on May 6, 2024 at the SMX Convention Center. His office is located at Cebu Doctors' University Hospital Medical Arts Building 1, Suite 303-A, Osmeña Blvd. Cebu City Philippines. Office hours are 9am-12pm Mon-Sat. Tel: 032-511-2857 Mobile/Viber: 0918-457-4762 . By appointment only.A Paradigm Shift in Atrial Fibrillation Management
Almost 10yrs ago in 2014, I started my own AF/Stroke Prevention protocol and reported my own observation in my own blog that I published in July 24, 2019. I reported my personal thoughts about how to unmask AF and prevent its ugly twin called stroke. Our society in cardiology did not have any guideline and data was replete on how we detect and manage the high risk patients with occult Atrial Fibrillation. I wrote about how I screen my high risk patients for stroke with the use of a simple legacy equipment called Holter Monitor. When I started to discover short bursts of SVT's (Supraventricular Tachycardia) called Micro-AF, my dilemna started as if I may have inadvertently opened the pandora's box. A decision needs to be made as to whether to ignore and leave it as what our guideline would suggest or should I intervene and nip it at the bud with anti-arrhythmic medication. The decision did not come easy but, with a reasonable logic and being upfront with my patients, I decided to share the decision regarding intervention with them. Most if not all of my patients would want me to proceed. I discussed and sometimes argue my findings with my colleagues and try to defend my protocol including the so called experts in the field. Almost everyone would look at my thought process as off, scary and outright potentially dangerous considering the paucity of data to defend it. They are absolutely correct in their own right because my protocol did not have the necessary data to back it up. We doctors, have always been wired to follow guidelines and data in our day to day practice. I am not saying that it is bad but, if we get 100% dependent on data that may never be available in all of our every day encounter with patients, then we should start using our God-given gift called common sense.
Fast forward 10yrs later, the EAST AFNET-4 was published by the American College of Cardiology in Oct. 11, 2024. This landmark clinical trial proved to be the beginning of a paradigm shift in the way we handle and manage our AF patients. This trial was terminated early in favor of the Early Rhythm Strategy, a strategy I employed since 2014 which was not embraced by many is now the "in thing " and very much the way to go. I felt vindicated and thankful for the over 10yrs that my patients have benefited from an intervention that nobody would readily accept at that time. This proves over and over again that guidelines will always be a work in progress and we doctors need to open our minds and think outside the box. We should always remember and not lose sight of the fact that sharing the decision with the patient is of paramount importance when untested protocols are being implemented. Fear is normal, but what I can say is if you follow science it is difficult to go wrong and when you add knowledge into that critical thinking, reason will overcome whatever apprehension you may have and fear will slowly ease away.
Sunday, January 30, 2022
Covid Breakthrough Infection....a Big Misnomer!
The reason covid is still raging hard around the world is due to the high prevalence of unprotected people mainly for two reasons.
Inequitable distribution of vaccines and the predominance of antivaxers. Vaccine non-believers continue to deny the value of not only personal protection but also against the benefits of covid immunization. For whatever reason it maybe one thing that fuels more of their skepticism is perfectly our own fault of which I shall explain.
We've pretty much heard of the word "breakthrough infection" after covid immunization including those that received their booster shot. This is to me a very inappropriate word to use in light of the fact that was never intended to prevent infection 100% of the time. The idea dates back to our experience with the common flu virus. We give flu shots yearly despite the fact that we know it cannot prevent symptomatic infection 100% of the time, however, if an immunized individual gets the flu, it makes the experience a walk in the park. That has always been the idea of immunization. Fast forward covid vaccine, for some reason somehow the standards changed with the idea that immunization is thought of as a 100% shield against symptomatic infection...a big MISTAKE! This dates back from the time how mRNA vaccine makers define vaccine efficacy. Their phase-3 trials have shown that at least 95% of the time symptomatic infection is prevented and since then the bar on vaccine efficacy has become so high that it is virtually impossible to replicate it in the real world. The word breakthrough implies failure and therefore should be discouraged. This definition merely fuels the antivaxers into believing that despite immunization people are still getting sick so why should we get immunized?
We know from real world experience that with our current surge the mortality from Omicron variant were almost always coming from the unvaccinated while those who got immunized and boosted death was prevented 95% of the time. Isn't this a big enough proof of vaccine efficacy? Experts are now starting to believe that the bug is slowly behaving like an ordinary flu for the vaccinated and boosted.
The world can only heal as one and for as long as there is an no equitable distribution of vaccines normalcy will be difficult to achieve. For now the question we should ask ourselves as healthcare providers is to avoid using the word breakthrough infection as I have already alluded to earlier. It is time to get our act together and get over with our alarmist view and look at all these based on reason rather than emotion.
Tuesday, November 03, 2020
Covid-19 " Cytokine Storm " a Misnomer?
When Covid-19 came into this world, we soon realized that the havoc wreaked by such a novel virus is due to the accumulation of inflammatory cytokines of which medical experts describe as " Cytokine Storm". This remains to be the prevailing theory up to this time and our local experience echos what has been observed. The presence of a persistent and unrelenting rise in measurable inflammatory cytokines among Covid-19 infected patients that is responsible for determining the overall clinical outcome.
After having seen quite a few Covid-19 infected patients, my view has changed. I look at “cytokine storm” as a misnomer because it seems to imply a sudden unpredictable surge in inflammatory levels. I prefer to describe Covid-19 infection as "an inflammatory condition associated with a progressive cytokine build-up". Our body compensates very well early on as these cytokines start building up but, it comes to a point when the body’s compensatory
mechanisms start to fail and clinically failure comes in two phases:
Wednesday, July 24, 2019
Unmasking AF and its Evil Twin: STROKE
Wednesday, September 16, 2015
The Art of Medical Practice: What is the Ideal BP?
In the latest publication from a NIH-sponsored study SPRINT (Systolic Blood Pressure Intervention Trial) on 9,200 patients published Sept. 11, 2015 conclusively showed a significant reduction by almost a third in the incidence of myocardial infarction, congestive heart failure and stroke for those randomized to a target BP of 120mmHg vs the recommended 140mmHg. This same group also benefited by having a reduced incidence of overall death by almost a quarter.
It is not the intention of this article to bash on guidelines because it is for the most part evidence-based and our way of measuring what good clinical practice is all about. It is my belief however, that physicians must not feel hostage to it and it is hoped that we physicians exercise open-mindedness and independence even if it means thinking outside the box to do what is best for our patient because after all, the practice of medicine is an art and not a perfect science.
Sunday, April 28, 2013
The Healing Power of LOVE!
Monday, March 04, 2013
Stem Cell Therapy: Fact? or Fiction?
Monday, November 12, 2012
Tips to Handle the Anxious Patient
Monday, June 18, 2012
Simple Tips on How to find the right doctor!
Sunday, January 29, 2012
Top 5 important information about Hypertension
2. Hypertension has a genetic predisposition in more than 90% of the time. In short, this is a genetic problem that we inherit from our parents and blood related relatives.
Thursday, July 29, 2010
Calcium Supplements can break your heart!!
This finding is in keeping with what we already know with most other studies on the benefits of supplements including antioxidants where no documentation of benefit were seen when these supplements taken orally in a tablet form.
Tuesday, November 17, 2009
Common misconceptions about EGGS!
Wednesday, February 11, 2009
Eggs Galore.....
Wednesday, December 10, 2008
What Now for Vytorin? In? or Out?
In medicine, our dictum is to do no harm. We have not seen harm done on patients with vytorin...that one study showed us that it " may " not be doing what it is supposed to do. We also need to mention that Simvastatin which is the statin component of vytorin has tons of proofs for the benefit our patients get from the drug hence, it just does not make sense why additional reduction of LDLc could hurt our patients?
Tuesday, March 18, 2008
State of the Art in Cebu!
For more information, comments, or inquiries, please email me at: EdgarTan62@yahoo.com.
Wednesday, January 09, 2008
PCI vs CABG: Is it really an option?
Sunday, November 11, 2007
Mitral Valve Prolapse: No longer indicated for Endocarditis Prophylaxis
Saturday, September 08, 2007
Homocysteine and CAD: Are Folates Protective?
